Dynamic changes of serum hbv pgrna levels in patients with chronic hepatitis B treated with entecavir or peg-interferon

被引:1
|
作者
Yu, Xiaoqi [1 ]
Yu, Demin [1 ]
Chen, Peizhan [2 ]
Gong, Qiming [3 ]
Zhang, Xinxin [1 ,2 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Res Lab Clin Virol, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp North, Translat Med Res Ctr, Shanghai, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China
关键词
D O I
10.1016/S0618-8278(19)30963-6
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
FRI-218
引用
收藏
页码:E490 / E490
页数:1
相关论文
共 50 条
  • [41] HBcrAg levels at baseline are not predictive for HBsAg and HBeAg loss in patients treated with adefovir and PEG-interferon
    Erken, Robin
    Zaaijer, Hans
    Bakker, Ed
    Kootstra, Neeltje
    Reesink, Henk
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E256 - E256
  • [42] Chronic hepatitis B: Predictive value of serum ALT and HBV DNA levels on response to interferon.
    Areias, J
    Pedroto, I
    Pocas, C
    Cerqueira, R
    Pinho, L
    Justica, B
    Pinho, C
    HEPATOLOGY, 1997, 26 (04) : 1385 - 1385
  • [43] PERSISTENTLY DETECTABLE SERUM HBV DNA AND PGRNA IS ASSOCIATED WITH SUBSEQUENT HCC DEVELOPMENT IN CHRONIC HEPATITIS B PATIENTS RECEIVING CHRONIC NRTI TREATMENT
    Mak, Lung Yi
    Huang, Qi
    Wong, Ka Ho Danny
    Yan, Ran
    Ouyang, Lea
    Fung, James
    Seto, Wai Kay Walter
    Yuen, Man Fung
    HEPATOLOGY, 2020, 72 : 448A - 448A
  • [44] Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B
    Huang, Yi-Wen
    Chayama, Kazuaki
    Tsuge, Masataka
    Takahashi, Shoichi
    Hatakeyama, Tsuyoshi
    Abe, Hiromi
    Hu, Jui-Ting
    Liu, Chun-Jen
    Lai, Ming-Yang
    Chen, Ding-Shinn
    Yang, Sien-Sing
    Kao, Jia-Horng
    ANTIVIRAL THERAPY, 2010, 15 (02) : 177 - 184
  • [45] Changes of serum HBsAg levels in HBeAg-negative chronic hepatitis B patients treated with tenofovir
    Papatheodoridis, George V.
    Triantos, Christos K.
    Hadziyannis, Emilia
    Zisimopoulos, Konstantinos
    Georgiou, Anastasia
    Margariti, Katerina
    Deutsch, Melanie
    Nikolopoulou, Vasiliki
    Manolakopoulos, Spilios
    HEPATOLOGY, 2013, 58 : 686A - 687A
  • [46] Correlation of HBV DNA levels in serum and liver of chronic hepatitis B patients with cirrhosis
    Lee, CZ
    Huang, GT
    Yang, PM
    Sheu, JC
    Lai, MY
    Chen, DS
    LIVER, 2002, 22 (02): : 130 - 135
  • [47] SERUM HEPATITIS B SURFACE ANTIGEN LEVELS DURING FIVE YEARS ENTECAVIR THERAPY IN ASIAN CHRONIC HEPATITIS B PATIENTS
    Seto, W. -K.
    Lam, Y. -F.
    Fung, J.
    Wong, D. K. -H.
    Lai, C. -L.
    Yuen, M. -F.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S314 - S314
  • [48] Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
    Abdel-Rahman N Zekri
    Abeer A Bahnassy
    Waleed S Mohamed
    Hanaa M Alam EL-Din
    Hend I Shousha
    Naglaa Zayed
    Dina H Eldahshan
    Ashraf Omar Abdel-Aziz
    Virology Journal, 10
  • [49] Dynamic interplay between CXCL levels in chronic Hepatitis C patients treated by Interferon
    Zekri, Abdel-Rahman N.
    Bahnassy, Abeer A.
    Mohamed, Waleed S.
    EL-Din, Hanaa M. Alam
    Shousha, Hend I.
    Zayed, Naglaa
    Eldahshan, Dina H.
    Abdel-Aziz, Ashraf Omar
    VIROLOGY JOURNAL, 2013, 10
  • [50] Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes
    Boglione, L.
    D'Avolio, A.
    Cariti, G.
    Milia, M. G.
    Simiele, M.
    De Nicolo, A.
    Ghisetti, V.
    Di Perri, G.
    JOURNAL OF VIRAL HEPATITIS, 2013, 20 (04) : e11 - e19